News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
397,731 Results
Type
Article (11869)
Company Profile (115)
Press Release (385745)
Multimedia
Podcasts (8)
Webinars (3)
Section
Business (123944)
Career Advice (405)
Deals (21565)
Drug Delivery (42)
Drug Development (43564)
Employer Resources (36)
FDA (8679)
Job Trends (10539)
News (199022)
Policy (17105)
Tag
Academia (1685)
Accelerated approval (10)
Adcomms (6)
Allergies (97)
Alliances (21354)
ALS (97)
Alzheimer's disease (933)
Antibody-drug conjugate (ADC) (170)
Approvals (8941)
Artificial intelligence (243)
Autoimmune disease (67)
Automation (19)
Bankruptcy (147)
Best Places to Work (9401)
BIOSECURE Act (10)
Biosimilars (82)
Biotechnology (46)
Bladder cancer (101)
Brain cancer (32)
Breast cancer (434)
Cancer (2988)
Cardiovascular disease (238)
Career advice (340)
Career pathing (9)
CAR-T (169)
CDC (9)
Cell therapy (426)
Cervical cancer (27)
Clinical research (38884)
Collaboration (838)
Compensation (458)
Complete response letters (25)
COVID-19 (1252)
CRISPR (55)
C-suite (382)
Cystic fibrosis (82)
Data (4173)
Depression (68)
Diabetes (268)
Diagnostics (4495)
Digital health (21)
Diversity (4)
Diversity, equity & inclusion (11)
Drug discovery (100)
Drug pricing (53)
Drug shortages (8)
Duchenne muscular dystrophy (124)
Earnings (73585)
Editorial (17)
Employer branding (6)
Employer resources (34)
Events (78567)
Executive appointments (578)
FDA (10682)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (17)
Funding (786)
Gene editing (123)
Generative AI (14)
Gene therapy (303)
GLP-1 (433)
Government (2568)
Grass and pollen (5)
Guidances (368)
Healthcare (15114)
HIV (31)
Huntington's disease (24)
IgA nephropathy (53)
Immunology and inflammation (129)
Immuno-oncology (22)
Indications (51)
Infectious disease (1387)
Inflammatory bowel disease (128)
Inflation Reduction Act (7)
Influenza (70)
Intellectual property (109)
Interviews (63)
IPO (12669)
IRA (8)
Job creations (1420)
Job search strategy (298)
Kidney cancer (10)
Labor market (39)
Layoffs (246)
Leadership (4)
Legal (3535)
Liver cancer (48)
Longevity (6)
Lung cancer (434)
Lymphoma (268)
Machine learning (13)
Management (11)
Manufacturing (356)
MASH (98)
Medical device (9843)
Medtech (9868)
Mergers & acquisitions (9635)
Metabolic disorders (612)
Multiple sclerosis (97)
NASH (5)
Neurodegenerative disease (156)
Neuropsychiatric disorders (39)
Neuroscience (1639)
NextGen: Class of 2025 (5249)
Non-profit (4231)
Now hiring (21)
Obesity (238)
Opinion (75)
Ovarian cancer (103)
Pain (110)
Pancreatic cancer (127)
Parkinson's disease (178)
Partnered (14)
Patents (216)
Patient recruitment (221)
Peanut (42)
People (27844)
Pharmaceutical (15)
Pharmacy benefit managers (11)
Phase I (11533)
Phase II (17062)
Phase III (13888)
Pipeline (2969)
Policy (63)
Postmarket research (1182)
Preclinical (4027)
Press Release (61)
Prostate cancer (130)
Psychedelics (11)
Radiopharmaceuticals (156)
Rare diseases (433)
Real estate (2779)
Recruiting (16)
Regulatory (13310)
Reports (20)
Research institute (1524)
Resumes & cover letters (73)
Rett syndrome (19)
RNA editing (5)
RSV (34)
Schizophrenia (95)
Series A (132)
Series B (99)
Service/supplier (5)
Sickle cell disease (60)
Special edition (10)
Spinal muscular atrophy (93)
Sponsored (16)
Startups (1335)
State (1)
Stomach cancer (3)
Supply chain (43)
Tariffs (25)
The Weekly (8)
Vaccines (389)
Venture capital (24)
Weight loss (126)
Women's health (42)
Worklife (3)
Date
Today (63)
Last 7 days (278)
Last 30 days (1364)
Last 365 days (22064)
2025 (21633)
2024 (22586)
2023 (26924)
2022 (30893)
2021 (34999)
2020 (37341)
2019 (37139)
2018 (27039)
2017 (19874)
2016 (19678)
2015 (23178)
2014 (12765)
2013 (9617)
2012 (10164)
2011 (10407)
2010 (9421)
Location
Africa (293)
Alabama (53)
Alaska (2)
Arizona (162)
Arkansas (7)
Asia (24380)
Australia (3198)
California (7235)
Canada (1843)
China (820)
Colorado (308)
Connecticut (286)
Delaware (246)
Europe (47235)
Florida (1054)
Georgia (249)
Idaho (38)
Illinois (550)
India (41)
Indiana (423)
Iowa (14)
Japan (248)
Kansas (74)
Kentucky (30)
Louisiana (19)
Maine (65)
Maryland (1022)
Massachusetts (5252)
Michigan (192)
Minnesota (428)
Mississippi (5)
Missouri (88)
Montana (27)
Nebraska (16)
Nevada (78)
New Hampshire (62)
New Jersey (2172)
New Mexico (18)
New York (2043)
North Carolina (993)
North Dakota (4)
Northern California (3560)
Ohio (226)
Oklahoma (15)
Oregon (21)
Pennsylvania (1537)
Puerto Rico (8)
Rhode Island (31)
South America (527)
South Carolina (36)
South Dakota (1)
Southern California (2806)
Tennessee (108)
Texas (1092)
United States (26563)
Utah (242)
Vermont (1)
Virginia (180)
Washington D.C. (51)
Washington State (593)
West Virginia (1)
Wisconsin (55)
397,731 Results for "30".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025
November 14, 2025
·
5 min read
Press Releases
Sensient Declares Dividend - October 30, 2025
October 31, 2025
·
1 min read
Press Releases
Curis to Present at Upcoming 30th Annual SNO Meeting
November 17, 2025
·
2 min read
Press Releases
Medicure Reports Financial Results for Quarter Ended September 30, 2025
November 20, 2025
·
14 min read
Breast cancer
Roche’s Oral SERD Cuts Death Risk by 30% in Early-Stage Breast Cancer
While overall survival remains immature, results so far show a clear trend in favor of Roche’s giredestrant.
December 11, 2025
·
2 min read
·
Tristan Manalac
Approvals
GSK’s Blujepa Opens First New Class of Gonorrhea Antibiotic in More Than 30 Years
Blujepa is also approved for uncomplicated urinary tract infection in females 12 years and older.
December 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Ascletis to Present Study Results of ASC30 Oral Tablet, ASC30 Injection, and Combination of ASC31 and ASC47 at ObesityWeek® 2025
October 27, 2025
·
3 min read
Press Releases
DNA Synthesis Market Size to Lead USD 30,320 Million by 2034
November 20, 2025
·
1 min read
Press Releases
Organon Reports Results for the Third Quarter Ended September 30, 2025
November 11, 2025
·
21 min read
Press Releases
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
November 14, 2025
·
10 min read
1 of 39,774
Next
